![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 41, 31609-31615, October 13, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the Intracellular iron homeostasis is regulated, in
part, by interactions between iron-regulatory proteins (IRP1 and IRP2)
and iron-responsive elements (IREs) in ferritin and transferrin
receptor mRNAs. In addition to iron, cellular oxidative stress
induced by H2O2, nitric oxide, and
hypoxia, and hormonal activation by thyroid hormone and erythropoeitin
have each been shown to regulate IRP binding to IREs. Hormonal signals,
in particular mediated through protein kinase C (PKC), play a central
role in the modulation of IRP/IRE interactions since phorbol esters
were shown to activate IRP binding (Eisenstein, R. S., Tuazon,
P. T., Schalinske, K. L., Anderson, S. A., and Traugh,
J. A. (1993) J. Biol. Chem. 268, 27363-27370).
In pituitary thyrotrophs (TtT97), we found that thyrotropin releasing
hormone (TRH) and epidermal growth factor (EGF) increased IRP binding
to a ferritin IRE, dependent on PKC and mitogen-activated protein
kinase (MAPK) activity. In contrast, TRH and EGF decreased IRP binding
in pituitary lactotrophs (GH3), despite activation of PKC and MAPK.
IRP1 and IRP2 levels remained constant and IRP2 binding was predominant
throughout. TRH and EGF markedly decreased IRP binding in MAPK kinase
inhibitor-treated GH3 cells, whereas, they increased IRP binding in
phosphatase inhibitor-treated GH3 cells. IRE-dependent CAT
reporter translational expression closely reflected IRP binding to the
ferritin IRE in both GH3 and TtT97 cells. Interestingly, ferritin
protein levels were regulated similarly by TRH in both cell lines.
These data link two different cell receptor systems to common signaling
pathways that regulate IRP binding and ferritin expression. Remarkably, for TRH and EGF, these effects may be PKC-dependent or
-independent determined by the cell type.
Laboratory for Cancer Medicine and
University Department of Medicine, University of Western Australia,
Western Australian Institute for Medical Research, Royal Perth
Hospital, Perth, Western Australia 6000, Australia and the
§ Genetics and Aging Unit, Massachusetts General Hospital
(East), Harvard Medical School,
Charlestown, Massachusetts 02129
This article has been cited by other articles:
![]() |
K. Tatematsu, N. Yoshimoto, T. Okajima, K. Tanizawa, and S. Kuroda Identification of Ubiquitin Ligase Activity of RBCK1 and Its Inhibition by Splice Variant RBCK2 and Protein Kinase C{beta} J. Biol. Chem., April 25, 2008; 283(17): 11575 - 11585. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Luo, N. Yano, and J. Z. Q. Luo The molecular mechanism of EGF receptor activation in pancreatic beta-cells by thyrotropin-releasing hormone Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E889 - E899. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Thomson, C. M. Cahill, H.-H. Cho, K. D. Kassachau, M. R. Epis, K. R. Bridges, P. J. Leedman, and J. T. Rogers The Acute Box cis-Element in Human Heavy Ferritin mRNA 5'-Untranslated Region Is a Unique Translation Enhancer That Binds Poly(C)-binding Proteins J. Biol. Chem., August 26, 2005; 280(34): 30032 - 30045. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Reese, C. Davidson, M. L. Billingsley, and J. Yun Protein Kinase C{epsilon} Regulates Tumor Necrosis Factor-{alpha}-Induced Stannin Gene Expression J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 61 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Kiemer, A. C. Fornges, K. Pantopoulos, M. Bilzer, B. Andriopoulos, T. Gerwig, S. Kenngott, A. L. Gerbes, and A. M. Vollmar ANP-induced decrease of iron regulatory protein activity is independent of HO-1 induction Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G518 - G526. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Adams, D. J. Beveridge, L. van der Weyden, H. Mangs, P. J. Leedman, and B. J. Morris HADHB, HuR, and CP1 Bind to the Distal 3'-Untranslated Region of Human Renin mRNA and Differentially Modulate Renin Expression J. Biol. Chem., November 7, 2003; 278(45): 44894 - 44903. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Rogers, J. D. Randall, C. M. Cahill, P. S. Eder, X. Huang, H. Gunshin, L. Leiter, J. McPhee, S. S. Sarang, T. Utsuki, et al. An Iron-responsive Element Type II in the 5'-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript J. Biol. Chem., November 15, 2002; 277(47): 45518 - 45528. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Yeap, D. C. Voon, J. P. Vivian, R. K. McCulloch, A. M. Thomson, K. M. Giles, M. F. Czyzyk-Krzeska, H. Furneaux, M. C. J. Wilce, J. A. Wilce, et al. Novel Binding of HuR and Poly(C)-binding Protein to a Conserved UC-rich Motif within the 3'-Untranslated Region of the Androgen Receptor Messenger RNA J. Biol. Chem., July 19, 2002; 277(30): 27183 - 27192. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Brazzolotto, P. Timmins, Y. Dupont, and J.-M. Moulis Structural Changes Associated with Switching Activities of Human Iron Regulatory Protein 1 J. Biol. Chem., March 29, 2002; 277(14): 11995 - 12000. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Albert Editorial: Dopamine-D2-Mediated Inhibition of TRH-Induced PLC Activation in Pituitary Cells--Direct or Indirect? Endocrinology, March 1, 2002; 143(3): 744 - 746. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |